Home > Healthcare > Gas Exchange Pulmonary Function Testing Market > Table of Contents

Gas Exchange Pulmonary Function Testing Market – By System Type, By Test Method, By Application, By End Use, Global Forecast, 2024 – 2032

  • Report ID: GMI11737
  • Published Date: Oct 2024
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definition

1.2    Research design

1.2.1    Research approach

1.2.2    Data collection methods

1.3    Base estimates & calculations

1.3.1    Base year calculation

1.3.2    Key trends for market estimation

1.4    Forecast model

1.5    Primary research and validation

1.5.1    Primary sources

1.5.2    Data mining sources

Chapter 2   Executive Summary

2.1    Industry 3600 synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1    Rising prevalence of respiratory diseases

3.2.1.2    Technological advancements

3.2.1.3    Expansion of healthcare infrastructure in emerging markets

3.2.2    Industry pitfalls & challenges

3.2.2.1    High cost associated with equipment

3.3    Growth potential analysis

3.4    Regulatory landscape

3.5    Reimbursement scenario

3.6    Technology landscape

3.7    Gap analysis

3.8    Porter's analysis

3.9    PESTEL analysis

3.10    Value chain analysis

3.11    Future market trends

Chapter 4   Competitive Landscape, 2023

4.1    Introduction

4.2    Company market share analysis

4.3    Company matrix analysis

4.4    Competitive analysis of major market players

4.5    Competitive positioning matrix

4.6    Strategy dashboard

Chapter 5   Market Estimates and Forecast, By System Type, 2021 – 2032 ($ Mn)

5.1    Key trends

5.2    Portable

5.3    Stationary

Chapter 6   Market Estimates and Forecast, By Test Method, 2021 – 2032 ($ Mn)

6.1    Key trends

6.2    Gas diffusion tests

6.3    Cardiopulmonary exercise testing (CPET)

Chapter 7   Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)

7.1    Key trends

7.2    Chronic obstructive pulmonary disease (COPD)

7.3    Asthma

7.4    Chronic shortness of breath

7.5    Pulmonary fibrosis

7.6    Other applications

Chapter 8   Market Estimates and Forecast, By End Use, 2021 – 2032 ($ Mn)

8.1    Key trends

8.2    Hospitals & clinics

8.3    Diagnostic centers

8.4    Other end users

Chapter 9   Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)

9.1    Key trends

9.2    North America

9.2.1    U.S.

9.2.2    Canada

9.3    Europe

9.3.1    Germany

9.3.2    UK

9.3.3    France

9.3.4    Spain

9.3.5    Italy

9.3.6    Netherlands

9.4    Asia Pacific

9.4.1    China

9.4.2    Japan

9.4.3    India

9.4.4    Australia

9.4.5    South Korea

9.5    Latin America

9.5.1    Brazil

9.5.2    Mexico

9.5.3    Argentina

9.6    Middle East and Africa

9.6.1    South Africa

9.6.2    Saudi Arabia

9.6.3    UAE

Chapter 10   Company Profiles

10.1    CHEST

10.2    COSMED

10.3    ECO MEDICS

10.4    Geratherm Medical

10.5    KoKo PFT

10.6    Koninklijke Philips

10.7    MGC Diagnostics Corporation

10.8    ndd Medical Technologies

10.9    PulmOne

10.10    SCHILLER

10.11    Vitalograph

10.12    Vyaire Medical

   

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2023
  • Companies covered: 12
  • Tables & Figures: 131
  • Countries covered: 23
  • Pages: 130
 Download Free Sample